Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Sun Pharmaceutical Gets FDA Approval for Epinastine Eye Drops

Nov. 2 (Bloomberg) -- Sun Pharmaceutical Industries Ltd., India’s biggest drugmaker by market value, received approval from the U.S. Food and Drug Administration for its epinastine hydrochloride eye drops, the generic version of Allergan Inc.’s Elestat anti-allergy medicine, according to a statement on the FDA website.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{AGN US <Equity> CN <GO>} Link to Company News:{SUNP IN <Equity> CN <GO>}

To contact the reporter on this story: Adi Narayan in Mumbai at

To contact the editor responsible for this story: Niveditha Ravi at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.